Form D · Biotechnology
Snap Bio, Inc.
San Diego, CA · CIK 0001750719
Offering snapshot reported Aug 21, 2018 · SEC filing
- Reported sold
- $1.66M Offering amount: $3.2M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 6, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 21, 2018 | Initial | $1,658,323 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-319669
Source: Form D, filed Aug 21, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Burk | Director, Executive |
| Andy Li | Director |
| Christophe Schilling | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4757 Nexus Center Drive
San Diego, CA, 92121
San Diego, CA, 92121